Selecta Biosciences held its 2023 Annual Meeting of Stockholders, where directors were elected, executive officer compensation was approved, an amendment to the Certificate of Incorporation was not approved, and the appointment of Ernst & Young LLP as the independent registered public accounting firm was ratified.